Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02628678 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers
A NA study, sponsored by Kaleido Biosciences.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT02628678: Completed NA study, sponsored by Kaleido Biosciences.
NCT02628678 is a NA study that has completed, run by Kaleido Biosciences. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02628678, a NA study, has completed, sponsored by Kaleido Biosciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
The primary objective of this study is to determine the 5-day tolerability of one commercially available prebiotic food ingredient, FOS, in healthy human subjects with and without diet control.
Interventions
- DIETARY_SUPPLEMENT FOS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2015-11 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02628678 record still lists
NCT02628678 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which FOS is the first listed.
NCT02628678 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02628678 about?
NCT02628678 is a clinical study titled "A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers". The primary objective of this study is to determine the 5-day tolerability of one commercially available prebiotic food ingredient, FOS, in healthy human subjects with and without diet control.
What is the current status of trial NCT02628678?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2015-11. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02628678?
The interventions under investigation include: FOS (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02628678?
This trial is sponsored by Kaleido Biosciences, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02628678's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia